Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.

The aims of the present study were to elucidate a possible mechanism of kidney crystal formation by using a metabolic syndrome (MetS) mouse model and to assess the effectiveness of adiponectin treatment for the prevention of kidney crystals. Further, we performed genome-wide expression analyses for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yasuhiro Fujii, Atsushi Okada, Takahiro Yasui, Kazuhiro Niimi, Shuzo Hamamoto, Masahito Hirose, Yasue Kubota, Keiichi Tozawa, Yutaro Hayashi, Kenjiro Kohri
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cd6f4b187102489b8f52dec9bc43648e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cd6f4b187102489b8f52dec9bc43648e
record_format dspace
spelling oai:doaj.org-article:cd6f4b187102489b8f52dec9bc43648e2021-11-18T07:48:35ZEffect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.1932-620310.1371/journal.pone.0061343https://doaj.org/article/cd6f4b187102489b8f52dec9bc43648e2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23630583/?tool=EBIhttps://doaj.org/toc/1932-6203The aims of the present study were to elucidate a possible mechanism of kidney crystal formation by using a metabolic syndrome (MetS) mouse model and to assess the effectiveness of adiponectin treatment for the prevention of kidney crystals. Further, we performed genome-wide expression analyses for investigating novel genetic environmental changes. Wild-type (+/+) mice showed no kidney crystal formation, whereas ob/ob mice showed crystal depositions in their renal tubules. However, this deposition was remarkably reduced by adiponectin. Expression analysis of genes associated with MetS-related kidney crystal formation identified 259 genes that were >2.0-fold up-regulated and 243 genes that were <0.5-fold down-regulated. Gene Ontology (GO) analyses revealed that the up-regulated genes belonged to the categories of immunoreaction, inflammation, and adhesion molecules and that the down-regulated genes belonged to the categories of oxidative stress and lipid metabolism. Expression analysis of adiponectin-induced genes related to crystal prevention revealed that the numbers of up- and down-regulated genes were 154 and 190, respectively. GO analyses indicated that the up-regulated genes belonged to the categories of cellular and mitochondrial repair, whereas the down-regulated genes belonged to the categories of immune and inflammatory reactions and apoptosis. The results of this study provide compelling evidence that the mechanism of kidney crystal formation in the MetS environment involves the progression of an inflammation and immunoresponse, including oxidative stress and adhesion reactions in renal tissues. This is the first report to prove the preventive effect of adiponectin treatment for kidney crystal formation by renoprotective activities and inhibition of inflammation and apoptosis.Yasuhiro FujiiAtsushi OkadaTakahiro YasuiKazuhiro NiimiShuzo HamamotoMasahito HiroseYasue KubotaKeiichi TozawaYutaro HayashiKenjiro KohriPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 4, p e61343 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yasuhiro Fujii
Atsushi Okada
Takahiro Yasui
Kazuhiro Niimi
Shuzo Hamamoto
Masahito Hirose
Yasue Kubota
Keiichi Tozawa
Yutaro Hayashi
Kenjiro Kohri
Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.
description The aims of the present study were to elucidate a possible mechanism of kidney crystal formation by using a metabolic syndrome (MetS) mouse model and to assess the effectiveness of adiponectin treatment for the prevention of kidney crystals. Further, we performed genome-wide expression analyses for investigating novel genetic environmental changes. Wild-type (+/+) mice showed no kidney crystal formation, whereas ob/ob mice showed crystal depositions in their renal tubules. However, this deposition was remarkably reduced by adiponectin. Expression analysis of genes associated with MetS-related kidney crystal formation identified 259 genes that were >2.0-fold up-regulated and 243 genes that were <0.5-fold down-regulated. Gene Ontology (GO) analyses revealed that the up-regulated genes belonged to the categories of immunoreaction, inflammation, and adhesion molecules and that the down-regulated genes belonged to the categories of oxidative stress and lipid metabolism. Expression analysis of adiponectin-induced genes related to crystal prevention revealed that the numbers of up- and down-regulated genes were 154 and 190, respectively. GO analyses indicated that the up-regulated genes belonged to the categories of cellular and mitochondrial repair, whereas the down-regulated genes belonged to the categories of immune and inflammatory reactions and apoptosis. The results of this study provide compelling evidence that the mechanism of kidney crystal formation in the MetS environment involves the progression of an inflammation and immunoresponse, including oxidative stress and adhesion reactions in renal tissues. This is the first report to prove the preventive effect of adiponectin treatment for kidney crystal formation by renoprotective activities and inhibition of inflammation and apoptosis.
format article
author Yasuhiro Fujii
Atsushi Okada
Takahiro Yasui
Kazuhiro Niimi
Shuzo Hamamoto
Masahito Hirose
Yasue Kubota
Keiichi Tozawa
Yutaro Hayashi
Kenjiro Kohri
author_facet Yasuhiro Fujii
Atsushi Okada
Takahiro Yasui
Kazuhiro Niimi
Shuzo Hamamoto
Masahito Hirose
Yasue Kubota
Keiichi Tozawa
Yutaro Hayashi
Kenjiro Kohri
author_sort Yasuhiro Fujii
title Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.
title_short Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.
title_full Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.
title_fullStr Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.
title_full_unstemmed Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.
title_sort effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/cd6f4b187102489b8f52dec9bc43648e
work_keys_str_mv AT yasuhirofujii effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT atsushiokada effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT takahiroyasui effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT kazuhironiimi effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT shuzohamamoto effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT masahitohirose effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT yasuekubota effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT keiichitozawa effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT yutarohayashi effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
AT kenjirokohri effectofadiponectinonkidneycrystalformationinmetabolicsyndromemodelmiceviainhibitionofinflammationandapoptosis
_version_ 1718422938506493952